细胞衰老作为慢性肺疾病的机制与治疗靶点
本文综述细胞衰老在慢性阻塞性肺疾病(COPD)和特发性肺纤维化等慢性肺疾病中的驱动作用。衰老细胞通过p53/p21和p16INK4a/p21通路导致细胞周期停滞,并分泌衰老相关分泌表型引发低度慢性炎症。氧化应激下调PTEN激活PI3K-mTOR信号,经miR-34a和miR-570抑制sirtuin-1/6,加速衰老;抑制miR-34a或使用senolytic疗法在实验性肺纤维化中显示有效。
要点
- 细胞衰老通过p53/p21和p16INK4a/p21通路导致细胞周期停滞并驱动慢性肺疾病。
- 衰老相关分泌表型介导低度慢性炎症,进一步驱动衰老形成恶性循环。
- 抑制PI3K-mTOR信号、特定miRNA或senolytic疗法可能成为慢性肺疾病新治疗策略。
核心结论
- 细胞衰老是COPD和特发性肺纤维化等慢性肺疾病的重要驱动机制,靶向衰老相关通路可能提供新的治疗选择。
研究设计与样本
- 本文为综述,未报告系统检索范围与样本量。
主要发现
- 复制性衰老和应激性衰老分别通过激活p53和p16INK4a导致p21CIP1激活和细胞周期停滞。
- 衰老细胞分泌多种炎症蛋白即衰老相关分泌表型,导致低度慢性炎症并进一步驱动衰老。
- 氧化应激降低PTEN从而激活PI3K和mTOR,miR-34a受PI3K-mTOR调控并抑制sirtuin-1/6。
- 用antagomir抑制miR-34a可恢复sirtuin-1/6,减少衰老标志物和衰老相关分泌表型,并逆转COPD患者外周气道上皮细胞的细胞周期停滞。
- miR-570由p38 MAPK激活并参与sirtuin-1减少和细胞衰老;miRNA可经细胞外囊泡在肺内及经循环播散衰老。
临床怎么用
- 理解细胞衰老机制可能通过抑制PI3K-mTOR信号、抑制特定miRNA或使用senolytic疗法为慢性肺疾病提供新治疗。
- senolytic疗法已在实验性肺纤维化中显示有效。
局限性
- 本文为综述,未报告系统检索策略、纳入排除标准及原始研究数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cellular senescence is now considered an important driving mechanism for chronic lung diseases, particularly chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis. Cellular senescence is due to replicative and stress-related senescence with activation of p53 and p16INK4a, respectively, leading to activation of p21CIP1 and cell cycle arrest. Senescent cells secrete multiple inflammatory proteins known as the senescence-associated secretory phenotype, leading to low-grade chronic inflammation, which further drives senescence. Loss of key antiaging molecules sirtuin-1 and sirtuin-6 may be important in acceleration of aging and arises from oxidative stress reducing phosphatase PTEN (phosphatase tensin homolog), thereby activating PI3K (phosphoinositide-3-kinase) and mTOR (mammalian target of rapamycin). MicroRNA-34a (miR-34a), which is regulated by PI3K-mTOR signaling, plays a pivotal role in reducing sirtuin-1/6, and its inhibition with an antagomir results in their restoration, reducing markers of senescence, reducing senescence-associated secretory phenotype, and reversing cell cycle arrest in epithelial cells from peripheral airways of patients with COPD. miR-570 is also involved in reduction of sirtuin-1 and cellular senescence and is activated by p38 mitogen-activated protein kinase. These miRNAs may be released from cells in extracellular vesicles that are taken up by other cells, thereby spreading senescence locally within the lung but also outside the lung through the circulation; this may account for comorbidities of COPD and other lung diseases. Understanding the mechanisms of cellular senescence may result in new treatments for chronic lung disease, either by inhibiting PI3K-mTOR signaling, by inhibiting specific miRNAs, or by deletion of senescent cells with senolytic therapies, already shown to be effective in experimental lung fibrosis.
引用
- Barnes PJ, Baker J, Donnelly LE, et al. Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. Am J Respir Crit Care Med. 2019. PMID: 30860857. doi:10.1164/rccm.201810-1975TR
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。